Calvert Formula, Gates (m)
GFR, Gates
Calvert formula: Calculates the carboplatin dose using target AUC × (GFR + 25) to individualize exposure 1.
Gates (m): Estimates glomerular filtration rate from technetium‑99m MAG3 renal scintigraphy.
Indications for Use
Used to individualize carboplatin or radioisotope GFR-based dosing.
Indications (Calvert formula): Determining carboplatin dose by targeting AUC when renal function influences clearance; preferred when accurate GFR is available because exposure–response is well validated 1 [Level I evidence].
Clinical utility: Achieves predictable AUC‑based dosing and avoids toxicity under variable renal function; widely adopted due to validated therapeutic window 2 [Level III evidence].
Indications (Gates method): Nuclear medicine measurement of GFR for patients requiring precise dosing of renally cleared oncology drugs (e.g., carboplatin, high‑dose methotrexate) when eGFR is unreliable 3 [Level I evidence].
Clinical utility: Provides directly measured GFR to reduce dose error in cancer patients with inaccurate creatinine‑based estimates 4 [Level II evidence].
Insights & Cautions
Start with accurate GFR, because misestimation drives major dosing errors.
- Use measured GFR or creatinine–cystatin C combined eGFR when possible; this reduces carboplatin overdose by 3–4× versus creatinine alone in cancer patients 1 [Level II evidence].
- Caution: Creatinine-only estimates (especially Cockcroft–Gault) frequently misdose—overdose in low Cr, low BMI, sarcopenia; underdose in high GFR settings 2 [Level II evidence].
- Enzymatic creatinine methods can overestimate CrCl; adding +0.2 mg/dL reduces severe thrombocytopenia 3 [Level II evidence].
- Children: GFR estimation equation matters; cystatin‑C–based dosing more accurate and avoids overexposure 4 [Level II evidence].